Showing results (2431-2440 of 3,761) with videos related to

Sort By:
Pageof 377
Menopause (New York, N.Y.)|April 18, 2013
Does pattern recognition software using the Bahr monitor improve the sensitivity, specificity, and concordance of ambulatory skin conductance monitoring of hot flushes?Evgenia Stefanopoulou, Myra Sally Hunter
Menopause (New York, N.Y.)|April 18, 2013
Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?Maria E Bleil, Steven E Gregorich, Daniel McConnell, et al.
Menopause (New York, N.Y.)|April 4, 2013
Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean womenHyungChul Rah, Young Joo Jeon, Bo Eun Lee, et al.
Menopause (New York, N.Y.)|April 11, 2013
Quality of life and hypertension after hormone therapy withdrawal in New York CityMichelle P Warren, Olivia Richardson, Sonal Chaudhry, et al.
Menopause (New York, N.Y.)|February 14, 2013
Effects of adding alendronate to ongoing hormone therapy on bone mineral density in postmenopausal Korean women: a randomized, double-blind, placebo-controlled clinical trialYong-Ki Min, Dong-Yun Lee, Suk-Joo Choi, et al.
Menopause (New York, N.Y.)|February 14, 2013
Impact of the severity of vasomotor symptoms on health status, resource use, and productivityJennifer Whiteley, Jan-Samuel Wagner, Andrew Bushmakin, et al.
Menopause (New York, N.Y.)|March 14, 2013
Clinical profile of Spanish postmenopausal women with a diagnosis of osteoporosis and risk factors for endometrial pathology, breast cancer, and cardiovascular diseaseSantiago Palacios, José Luis Neyro, José Chaves Puertas, et al.
Menopause (New York, N.Y.)|January 31, 2013
Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophyDavid J Portman, Gloria A Bachmann, James A Simon, et al.
Menopause (New York, N.Y.)|February 26, 2013
Racial differences in perception of healthy body weight in midlife women: results from the Do Stage Transitions Result in Detectable Effects studySemara Thomas, Roberta B Ness, Rebecca C Thurston, et al.
Menopause (New York, N.Y.)|February 26, 2013
Unique symptoms at midlife of women with osteoporosis and cardiovascular disease in TaiwanHui-Ling Wang, Mei-Kuei Tai, Hsuan-Man Hung, et al.
Pageof 377